Literature DB >> 16963263

JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications.

Jean-Philippe Spano, Gerard Milano, Clivier Rixe, Remi Fagard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16963263     DOI： 10.1016/j.ejca.2006.07.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  28 in total

1.  St. John's Wort Attenuates Colorectal Carcinogenesis in Mice through Suppression of Inflammatory Signaling.

Authors:  Soumen K Manna; Srujana Golla; Jaya Prakash Golla; Naoki Tanaka; Yan Cai; Shogo Takahashi; Kristopher W Krausz; Tsutomu Matsubara; Ilia Korboukh; Frank J Gonzalez
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-11

2.  Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.

Authors:  Hua Xiong; Jie Hong; Wan Du; Yan-wei Lin; Lin-lin Ren; Ying-chao Wang; Wen-yu Su; Ji-lin Wang; Yun Cui; Zhen-hua Wang; Jing-Yuan Fang
Journal:  J Biol Chem       Date:  2011-12-28       Impact factor: 5.157

3.  Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer.

Authors:  Ganji Purnachandra Nagaraju; Batoul Farran; Matthew Farren; Gayathri Chalikonda; Christina Wu; Gregory B Lesinski; Bassel F El-Rayes
Journal:  Cancer       Date:  2020-05-08       Impact factor: 6.860

Review 4.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

Review 5.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  Functions and regulation of MUC13 mucin in colon cancer cells.

Authors:  Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan
Journal:  J Gastroenterol       Date:  2013-10-07       Impact factor: 7.527

7.  Prediction and experimental validation of novel STAT3 target genes in human cancer cells.

Authors:  Young Min Oh; Jong Kyoung Kim; Yongwook Choi; Seungjin Choi; Joo-Yeon Yoo
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

8.  Dissecting the human plasma proteome and inflammatory response biomarkers.

Authors:  Sudipto Saha; Scott H Harrison; Jake Yue Chen
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

9.  Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.

Authors:  Xuejun Tian; Ashley Pelton; Ali Shahsafaei; David M Dorfman
Journal:  Mod Pathol       Date:  2016-06-10       Impact factor: 7.842

10.  Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells.

Authors:  Hua Xiong; Zhi-Gang Zhang; Xiao-Qing Tian; Dan-Feng Sun; Qin-Chuan Liang; Yan-Jie Zhang; Rong Lu; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.